Related Experiment Video

Updated: Jul 16, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Inhibiting PTEN

E Rosivatz1

  • 1Division of Cell and Molecular Biology, Imperial College London, Exhibition Road, London, UK. e.rosivatz@ic.ac.uk

Biochemical Society Transactions
|March 21, 2007
PubMed

Insights

PTEN (phosphatase and tensin homologue deleted on chromosome 10) is a tumor suppressor that counteracts PI3K/Akt signaling. Its role in glucose uptake makes PTEN a potential drug target for diabetes and insulin resistance.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Endocrinology

Background:

  • PTEN (phosphatase and tensin homologue deleted on chromosome 10) functions as a tumor suppressor by dephosphorylating phosphoinositides.
  • PTEN counteracts phosphoinositide 3-kinase (PI3K) signaling, regulating cell motility, migration, cell-cycle progression, and proliferation.
  • Deregulation of PTEN/PI3K/Akt signaling is implicated in various cancers and metabolic disorders.

Purpose of the Study:

  • To review PTEN's multifaceted roles in glucose uptake, insulin resistance, and diabetes.
  • To discuss the controversial involvement of PTEN in glucose transporter (GLUT)-mediated glucose uptake.
  • To evaluate current PTEN inhibition techniques and its therapeutic potential in diabetes.

Main Methods:

  • Literature review of studies on PTEN's function in metabolic pathways.
  • Analysis of PTEN's role in insulin signaling and glucose homeostasis.
  • Discussion of PTEN inhibition strategies and their clinical relevance.

Main Results:

  • PTEN's lipid phosphatase activity is critical for regulating PI3K/Akt signaling, impacting cell growth and metabolism.
  • PTEN plays a complex role in insulin sensitivity and glucose uptake, with implications for type 2 diabetes.
  • Akt signaling, counteracted by PTEN, is central to insulin-regulated glucose metabolism.

Conclusions:

  • PTEN is a key regulator of glucose metabolism and insulin signaling, making it a promising drug target for diabetes.
  • Further research is needed to clarify PTEN's precise role in GLUT-mediated glucose transport.
  • Targeting PTEN offers potential therapeutic strategies for managing diabetes and related metabolic complications.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...